Article
[Description of Mycobacterium tuberculosis mutations conferring resistance to rifampicin and isoniazid detected by GenoType® MTBDRplus V.2 in Colombia].
Biomedica : revista del Instituto Nacional de Salud - 24 Jan 2017
Llerena Claudia, Medina Raquel
Abstract excerpt
INTRODUCTION: The GenoType®MTBDRplusV.2 assay is a molecular technique endorsed by the World Health Organization and the Pan American Health Organization that allows for the identification of the Mycobacterium tuberculosis complex and the detection of mutations in the rpoβ gene for rifampicin resistance, and katG and inhA genes for isoniazid resistance. Due to the genetic variability in the circulating strains...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
